Inositol levels, maintained by the biosynthetic enzyme inositol-3-phosphate synthase (Ino1), are altered in a range of disorders, including bipolar disorder and Alzheimer's disease. Here, ISYNA1 is linked to early-onset autosomal dominant Alzheimer disease.